Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
E. Donnall Thomas(Centre d'Investigation Clinique Antilles Guyane), Henri Roché(Inserm), Valorie F. Chan(National Cancer Center), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xavier Pivot(Levi Strauss (United States)), Henry Gómez(National Cancer Center), F Mendoza(National Cancer Center), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), Luis Fein(National Cancer Center), Judith Klimovsky(National Cancer Center), Mario Campone(Institut de Cancérologie de l'Ouest), Rubi K. Li(National Cancer Center), Guillermo Lerzo, Hyun Cheol Chung(Yonsei University), Jacek Jassem(Gdańsk Medical University)
Cited by 483
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k